Minnesota Governor Tim Walz signed the 2026 Omnibus Cannabis Bill into law on May 26, 2026, reshaping the regulatory framework for licensed cannabis businesses across the state. Sponsored by Representative Jessica Hanson (DFL-Burnsville), the legislation touches supply chain structure, medical cannabis access, license categories, and social equity pathways - and for operators currently holding medical cannabis combination business licenses, the clock is already running.
One Supply Chain Instead of Two
The most operationally significant change in the law is the consolidation of Minnesota's separate medical and adult-use supply chains into a single, unified structure. Under the previous framework, businesses serving both markets were required to maintain separate cultivation operations, separate manufacturing systems, and separate instances within Metrc - the state's seed-to-sale tracking platform. That meant duplicate compliance logs, segmented inventory, and parallel reporting obligations that added cost and administrative complexity without a clear benefit to either patients or regulators.
The merger eliminates that dual-track requirement. Businesses holding a medical cannabis endorsement will be able to serve registered patients and adult-use customers from the same cultivated product, the same manufacturing line, and a single Metrc instance. In practice, that should reduce overhead for multi-endorsement operators and simplify the compliance burden at the point-of-sale - a POS system tracking two separate inventory pools for the same physical product is not an efficient use of technology or staff time.
This wasn't improvised. The 2025 legislative session directed the Office of Cannabis Management to develop a formal supply chain streamlining proposal, covering co-location of cultivation and manufacturing, shared equipment, and continued patient access protections, particularly for patients with rare and childhood diseases. OCM delivered that proposal on January 15, 2026, following a six-month stakeholder engagement process involving patients, businesses, advocates, and Tribal partners. That proposal forms Article 3 of the omnibus bill - meaning this change arrived with an unusually detailed policy record behind it.
The Macrobusiness License: A New Tier at the Top
Effective January 1, 2027, the existing medical cannabis combination business license disappears. In its place: the macrobusiness, a new license category sitting at the top of Minnesota's tiered licensing structure. The macrobusiness is the only license type required to serve the medical market, and the obligations that come with it are specific.
Macrobusiness holders must maintain at least two medical endorsements. They can operate up to eight retail locations - but operators running more than five locations must ensure at least three of those locations are in areas that OCM has designated as high medical need areas. The total number of macrobusiness licenses is capped at eight before January 1, 2030. OCM is required to convert all existing medical cannabis combination business licenses and pending applications to macrobusiness licenses or applications by the January 1, 2027 effective date.
On canopy, here's where it gets complicated. The macrobusiness indoor canopy limit is set at 38,000 square feet - a substantial reduction from the 90,000 square feet currently permitted under the medical cannabis combination business license. For operators who have built cultivation infrastructure around the larger figure, that reduction isn't abstract. Representative Nolan West (R-Blaine), who described himself as broadly supportive of the bill, called the canopy reduction "the worst part of the bill" and raised the possibility of litigation from businesses that designed their operations under the prior limits.
The law does include a canopy growth pathway, though it moves slowly. After a macrobusiness completes its first license renewal and remains in good standing with OCM, it may receive an additional 2,000 square feet of plant canopy. A second renewal adds another 2,000 square feet. A third renewal adds 3,000 more. That brings a maximum eventual canopy - for a business that has successfully renewed three times and maintained good standing throughout - to 45,000 square feet. Still well below the 90,000-square-foot ceiling operators previously held.
Upward Mobility for Smaller Operators
The law also establishes a formal reclassification petition process for microbusinesses and mezzobusinesses seeking to move up the licensing tier ladder. Businesses can petition OCM for reclassification to a higher tier, with priority given to applicants that hold medical endorsements. Allocations are split equally between social equity and non-social equity operators.
This matters for the small-business segment of Minnesota's market. Microbusinesses operating within constrained canopy limits have had limited options for scaling without a formal mechanism to reclassify. The petition pathway, combined with the priority weighting for medical-endorsed businesses, creates an incentive structure that aligns small operator growth with the state's medical access objectives - a policy pairing that, on paper, serves both commercial and public health goals simultaneously.
What's striking here is the scope of the underlying process. Representative Hanson described the bill as the product of more than 80 stakeholders and three months of weekly meetings. For a bill that restructures seed-to-sale compliance infrastructure, creates a new license category, caps that license category, reduces canopy limits for the state's largest operators, and opens a reclassification pathway for smaller ones - that level of input-gathering is either thorough legislative work or a sign of how many competing interests were at the table. Likely both.
For dispensary operators, compliance teams, and investors with exposure to Minnesota's licensed cannabis market, the operative question right now isn't philosophical. It's operational: what does your license convert to on January 1, 2027, what does your Metrc configuration need to look like under a unified supply chain, and if you're a macrobusiness candidate running more than five retail locations, do any of them sit in a high medical need area as OCM will define it? The answers to those questions will shape what the next renewal cycle actually costs.
